
11 - 50 employees
Founded 2017
🧬 Biotechnology
🔧 Hardware
💰 $1.9M Debt Financing - Ciliatech on 2023-04
Biotechnology • Hardware
CILIATECH - Glaucoma Innovators is a medical technology company that develops the Intercil® Uveal Spacer, an implantable supraciliary device designed to lower intraocular pressure in primary open-angle and angle-closure glaucoma. The company emphasizes an ab-externo, bleb-free surgical approach that avoids entry into the anterior chamber, aiming to reduce endothelial cell risk and postoperative burdens while preserving future surgical options. CILIATECH supports its product with multi-year clinical trials and targets ophthalmic surgeons and professional audiences in glaucoma care.
🕒 May 15
International Medical & Scientific Affairs Manager at Ciliatech supporting the clinical adoption of glaucoma technology across Europe. Building partnerships with surgeons and conducting scientific communications with clinical stakeholders.
🇬🇧 United Kingdom – Remote
💰 $1.9M Debt Financing - Ciliatech on 2023-04
⏰ Full Time
🟡 Mid-level
🟠 Senior
👔 Manager